Japan· JP-7149009X1071

酒石酸

A sodium tartrate product containing 酒石酸, registered in Japan by 小堺製薬, on the national reimbursement list.

On Japan’s NHI price listATC A06AD21

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalised酒石酸ATCA06AD21REGISTER NO.JP-7149009X1071PACKS LISTED0CHECKEDOctober 2, 2026

The record

At a glance

MHLW / PMDA (Japan)
Active substance
酒石酸
Manufacturer
小堺製薬
Country
Japan (JP)
ATC code
A06AD21
ATC class
Sodium tartrate
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
October 2, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Sodium tartrate in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sodium tartrate products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3c0c7974-8c4e-4f0b-8d71-edd3c3a93bdf
GET /v1/drugs/3c0c7974-8c4e-4f0b-8d71-edd3c3a93bdf?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "10g",
  "marks": "局",
  "source": "mhlw",
  "remarks": null,
  "yj_code": "7149009X1071",
  "category": "内用薬",
  "price_yen": 27.4,
  "generic_name": "酒石酸",
  "product_name_jp": null,
  "therapeutic_class": "7149",
  "transitional_expiry": null
}

See everything about sodium tartrate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.